Alarm interventions for nocturnal enuresis in children.

What It Covers

Researchers studied Deamino Arginine Vasopressin in this systematic review publication.

To assess the effects of alarm interventions on nocturnal enuresis in children, and to compare alarms with other interventions.

Why It Was Studied

Although there is a high rate of spontaneous remission, the social, emotional and psychological costs to the children can be great.

The following electronic databases were searched: MEDLINE to June 1997; AMED; ASSIA; BIDS; BIOSIS Previews (1985-1996); CINAHL; DHSS Data; EMBASE (1974 to June 1997); PsycLIT and SIGLE.

Who the Included Studies Covered

PubMed indexes the participants as young children.

All randomised trials of alarm interventions for nocturnal enuresis in children were included in the review.

Trials were eligible for inclusion if: children were randomised to alarm treatment compared with controls, other behavioural methods or drugs for nocturnal bedwetting; participants with organic causes for their bedwetting were excluded; and baseline assessments of the level of bedwetting were reported.

What Was Measured

Two reviewers independently assessed the quality of the eligible trials, and extracted data.

PubMed files the paper under topics including Case-Control Studies, Deamino Arginine Vasopressin, Enuresis, Nephrology, Randomized Controlled Trials as Topic and Renal Agents.

What This Means in Plain Language

This is a systematic review of Deamino Arginine Vasopressin.

The abstract goes on to report its results in about 9 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2001 (The Cochrane database of systematic reviews), a journal based in England.

More context: all human trials.